Myeloid Panel Analysis Imperative for Risk Assessment in Patients With CCUS
A myeloid panel mutation analysis should be prioritized for patients with clonal cytopenia of undetermined significance (CCUS) as it can better assess patient risks for progression to a myeloid malignancy, a recent study argues.
Source: ajmc.com